HALO logo
halo search icon
NOVO.B
Novo Nordisk A/S Class B

NOVO.B · Novo Nordisk A/S Class B

307.75

DKK
7.80 (2.60%)
23/06/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr1.04T

PE

14.10

EV/EBITDA

10.4

DIV Yield

3.6%

Payout Ratio

51%

MQV Rating

3Neutral

As at 23/06/2026 12:00:00 AM

Price Chart

Description

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

  • All-Companies
  • All-Consensus
  • EMA 125 Breakup
  • Falling DPS over 2yrs
  • HALO 100
  • HALO 50
  • HALO All
  • HALO Capital Efficiency
  • HALO Earnings Momentum
  • HALO Small
  • Hammer Bullish (Realtime)
  • Near Resistance
  • Near Resistance (Realtime)

Key Fundamentals

EPS 3 yr Growth

88.10%

EBITDA Margin

48.40%

Operating Cashflow

kr119,102m

Free Cash Flow Return

43.60%

ROIC

37.50%

Interest Coverage

35.40

Quick Ratio

0.60

Performance

52 weeks range

Low 224.25 - 464.6

Trade Value (12mth)

US$83,706,368.00

1 week

9.79%

1 month

6.49%

YTD

-6.81%

1 year

-35.32%

All time high

1033.20

Additional Data

Shares Outstanding (Fully Diluted)

4,449m

HALO Sector

Healthcare

Next Company Report Date

03-Feb-27

Next Ex Dividend Date

27-Mar-26

Next Dividend Pay Date

31-Mar-26

Reporting Currency

DKK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Neutral

Garp

Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Novo Nordisk A/S Class B (NOVO.B:CSE)?
Halo FAQ
The current share price of Novo Nordisk A/S Class B (NOVO.B:CSE) is DKKkr307.75.
2
What is the 52-week high share price for Novo Nordisk A/S Class B (NOVO.B:CSE)?
Halo FAQ
The 52-week high share price for Novo Nordisk A/S Class B (NOVO.B:CSE) is DKKkr464.60.
3
What is the 52-week low share price for Novo Nordisk A/S Class B (NOVO.B:CSE)?
Halo FAQ
The 52-week low share price for Novo Nordisk A/S Class B (NOVO.B:CSE) is DKKkr224.25.
4
What is the dividend yield for Novo Nordisk A/S Class B (NOVO.B:CSE)?
Halo FAQ
The current TTM dividend payout for Novo Nordisk A/S Class B (NOVO.B:CSE) is 3.60.
5
What was Novo Nordisk A/S Class B (NOVO.B:CSE) last dividend payment?
Halo FAQ
The last dividend payment of Novo Nordisk A/S Class B (NOVO.B:CSE) is DKKkr7.95.
6
What is the franking level for Novo Nordisk A/S Class B (NOVO.B:CSE)?
Halo FAQ
Novo Nordisk A/S Class B (NOVO.B:CSE) has a franking level of 0.00%.
7
In which sector is Novo Nordisk A/S Class B (NOVO.B:CSE) classified?
Halo FAQ
Novo Nordisk A/S Class B (NOVO.B:CSE) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Novo Nordisk A/S Class B (NOVO.B:CSE)?
Halo FAQ
The current P/E ratio for Novo Nordisk A/S Class B (NOVO.B:CSE) is 14.10.